These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22799616)

  • 21. Long-term virological outcome in children receiving first-line antiretroviral therapy.
    Chandrasekaran P; Shet A; Srinivasan R; Sanjeeva GN; Subramanyan S; Sunderesan S; Ramesh K; Gopalan B; Suresh E; Poornagangadevi N; Hanna LE; Chandrasekar C; Wanke C; Swaminathan S
    AIDS Res Ther; 2018 Nov; 15(1):23. PubMed ID: 30477526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of Disclosure, Adherence and Viral Suppression in Children and Adolescents Living With HIV in Ecuador: A Cross-Sectional Study.
    García-Boyano M; Chávez-Solórzano N; Layana-Coronel M; Soffe-Pazmiño J; Sarcos-Lindao H; Solís-Montiel D; Miño-León G
    Pediatr Infect Dis J; 2022 Apr; 41(4):e133-e138. PubMed ID: 35027514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rate and predictors of self-chosen drug discontinuations in highly active antiretroviral therapy-treated HIV-positive individuals.
    Murri R; Guaraldi G; Lupoli P; Crisafulli R; Marcotullio S; von Schloesser F; Wu AW
    AIDS Patient Care STDS; 2009 Jan; 23(1):35-9. PubMed ID: 19183079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
    Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 'HIV is like a tsotsi. ARVs are your guns': associations between HIV-disclosure and adherence to antiretroviral treatment among adolescents in South Africa.
    Cluver LD; Hodes RJ; Toska E; Kidia KK; Orkin FM; Sherr L; Meinck F
    AIDS; 2015 Jun; 29 Suppl 1():S57-65. PubMed ID: 26049539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes after an unstructured treatment interruption in children and adolescents with perinatally acquired HIV infection.
    Saitoh A; Foca M; Viani RM; Heffernan-Vacca S; Vaida F; Lujan-Zilbermann J; Emmanuel PJ; Deville JG; Spector SA
    Pediatrics; 2008 Mar; 121(3):e513-21. PubMed ID: 18310171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and predictors of pediatric disclosure among HIV-infected Nigerian children on treatment.
    Odiachi A; Abegunde D
    AIDS Care; 2016 Aug; 28(8):1046-51. PubMed ID: 26883299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV status disclosure to perinatally-infected adolescents in Zimbabwe: a qualitative study of adolescent and healthcare worker perspectives.
    Kidia KK; Mupambireyi Z; Cluver L; Ndhlovu CE; Borok M; Ferrand RA
    PLoS One; 2014; 9(1):e87322. PubMed ID: 24475271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents.
    Krogstad P; Patel K; Karalius B; Hazra R; Abzug MJ; Oleske J; Seage GR; Williams PL; Borkowsky W; Wiznia A; Pinto J; Van Dyke RB;
    AIDS; 2015 Mar; 29(6):683-93. PubMed ID: 25849832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timing of and factors associated with HIV disclosure among perinatally infected children in rural Zambia.
    Sutcliffe CG; Drogt CS; van Dijk JH; Hamangaba F; Muleka M; Munsanje B; Munsanje J; Thuma PE; Moss WJ
    AIDS; 2020 Mar; 34(4):579-588. PubMed ID: 31651428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa.
    Nglazi MD; Kranzer K; Holele P; Kaplan R; Mark D; Jaspan H; Lawn SD; Wood R; Bekker LG
    BMC Infect Dis; 2012 Jan; 12():21. PubMed ID: 22273267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological Response of Hiv-Infected Children to Highly Active Antiretoviral Therapy at Gondar University Hospital, North-Western Ethiopia.
    Kokeb M; Degu G
    Ethiop J Health Sci; 2016 Jan; 26(1):25-30. PubMed ID: 26949313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV.
    MacDonell K; Naar-King S; Huszti H; Belzer M
    AIDS Behav; 2013 Jan; 17(1):86-93. PubMed ID: 23142855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orofacial outcomes in adolescents with perinatally infected HIV in antiretroviral therapy.
    Sampaio JDA; Jácome-Santos H; Aires AV; Pinheiro JJV; Abreu LG; Mesquita RA
    AIDS; 2020 Jul; 34(9):1417-1423. PubMed ID: 32590437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interventions to improve adherence to antiretroviral therapy in children with HIV infection.
    Bain-Brickley D; Butler LM; Kennedy GE; Rutherford GW
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD009513. PubMed ID: 22161452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychosocial implications of HIV serostatus disclosure to youth with perinatally acquired HIV.
    Santamaria EK; Dolezal C; Marhefka SL; Hoffman S; Ahmed Y; Elkington K; Mellins CA
    AIDS Patient Care STDS; 2011 Apr; 25(4):257-64. PubMed ID: 21323530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003).
    Peretti-Watel P; Spire B; Pierret J; Lert F; Obadia Y;
    AIDS Care; 2006 Apr; 18(3):254-61. PubMed ID: 16546787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioural health risks during early adolescence among perinatally HIV-infected South African adolescents and same-age, HIV-uninfected peers.
    Brittain K; Myer L; Phillips N; Cluver LD; Zar HJ; Stein DJ; Hoare J
    AIDS Care; 2019 Jan; 31(1):131-140. PubMed ID: 30340446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Escalating and sustained immunovirological dissociation among antiretroviral drug-experienced perinatally human immunodeficiency virus-1-infected children and adolescents living in the Central African Republic: A STROBE-compliant study.
    Mossoro-Kpinde CD; Gody JC; Mboumba Bouassa RS; Moussa S; Jenabian MA; Péré H; Charpentier C; Matta M; Longo JD; Grésenguet G; Djoba Siawaya JF; Bélec L
    Medicine (Baltimore); 2020 May; 99(21):e19978. PubMed ID: 32481261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Untangling the web: a close look at diagnosis disclosure among HIV-infected adolescents.
    Wiener LS; Battles HB
    J Adolesc Health; 2006 Mar; 38(3):307-9. PubMed ID: 16488835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.